Latest Posts
About This Stock
More About This Stock
Read
Read
Read
How To Invest In The Healthcare Sector
Article By:
Marc Lichtenfeld
Saturday, August 19, 2023 12:39 PM EDT
If things go wrong with some healthcare companies, investors often justify why they stay in the stock. And when things go right, they can go right in a hurry. Mersana Therapeutics is an example of how biotech stocks can experience these big swings.
How Biotech Stocks Are Revolutionizing Healthcare Investment Opportunities
Article By:
Hashtag Investing
Saturday, June 17, 2023 2:00 PM EDT
The field of biotechnology has become a driving force behind groundbreaking medical advancements, offering investors the opportunity to benefit from these innovations. Here are 10 healthcare innovators that are spearheading advancements in biotech.
Week In Review: Livzon In-Licenses GERD Therapy In $127 Million Agreement
Article By:
ChinaBio® Today
Saturday, March 18, 2023 2:40 PM EDT
Livzon Pharmaceutical Group entered a $127.5 million agreement for China rights to a gastroesophageal reflux disease therapy from Onconic Therapeutics. Meanwhile, Gracell Biotech announced that it had entered an unusual global deal with Seagen.
Large Cap Biopharmaceuticals Performance Update 2018: Part 2
Why did you decide to purchase $SGEN?
Seattle Genetics Receives FDA Halt On Several Phase 1 Studies
A real tragedy, not just for $SGEN investors, but for the families of those who died as a result of the trials. How likely is it that the company can bounce back from something like this?